Quipt Home Medical Corp.

Quipt Home Medical Corp. Acquisition: Shareholder Approval Paves Way for Privatization

Quipt Home Medical Corp., a U.S.-based provider of home medical equipment specializing in respiratory care, is moving towards becoming a private company. Its shareholders have overwhelmingly approved a plan for investment firms Kingswood Capital Management, L.P. and Forager Capital Management, LLC to acquire Quipt. This transaction will take Quipt from a publicly traded entity to private ownership.

Key Details of the Transaction:

• Acquisition Terms: Kingswood Capital Management and Forager Capital Management will buy all of Quipt's shares for US$3.65 in cash per share. This offers immediate and certain value to Quipt shareholders.
• Shareholder Approval: On March 3, 2026, Quipt shareholders overwhelmingly approved the transaction at a special meeting, with over 98% of votes cast in favor. This high approval rate highlights shareholder confidence in the deal's value.
• Board Recommendation: After a thorough review, Quipt's Board of Directors unanimously recommended shareholders vote for the arrangement, believing it serves the best interests of both the company and its shareholders.

Strategic Rationale:

The acquisition, first outlined in an Arrangement Agreement on December 14, 2025, aims to unlock shareholder value and give Quipt greater flexibility as a private company. Moving to private ownership is expected to enable Quipt to pursue long-term growth and operational improvements, free from the demands and expenses of being publicly traded.

Timeline and Next Steps:

• Court Approval: Quipt will seek a final order from the Supreme Court of British Columbia to approve the arrangement on March 5, 2026. This crucial legal step must occur for the transaction to move forward.
• Regulatory Approvals: The acquisition still requires all necessary regulatory approvals, such as antitrust clearances and other standard closing conditions.
• Expected Closing: If all conditions are met, the acquisition is expected to close "in the near term." Quipt will announce a specific closing date once finalized.
• Delisting: Once the transaction successfully closes, Quipt's shares will delist from both the NASDAQ and Toronto Stock Exchange (TSX), meaning they will no longer trade publicly.

Implications for Stakeholders:

• For Current Shareholders: Shareholders will receive US$3.65 in cash for each share they own. Once the deal closes, they will no longer hold shares in Quipt Home Medical Corp., and the shares will no longer trade on public exchanges.
• For Quipt Home Medical Corp.: Quipt will operate as a private company. Kingswood Capital Management and Forager Capital Management will guide its strategic direction and operational focus. This shift should bring new capital and strategic insights for future growth.
• For Customers: Quipt's core business of providing home medical equipment, especially respiratory care, should continue. The new owners' long-term strategy will determine any potential changes to services or offerings.

Investor Takeaways:

Investors can expect a certain US$3.65 cash payout per share for their Quipt holdings. As the company transitions to private ownership, its shares will no longer trade publicly after the deal closes. Investors should monitor the court approval outcome on March 5, 2026, and watch for subsequent announcements about the definitive closing date. For a full understanding of the transaction's terms, review the Management Information Circular dated January 23, 2026.